Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients

Aceruloplasminemia Clinical Trial

Official title: Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients

Status Recruiting

Clinical Trial Summary

Aceruloplasminemia is an autosomal recessive disorder characterized by iron deposition in the brain and visceral organs. Deferiprone was used to treat aceruloplasminemia in previous study. In this study, we will assess the clinical curative effect evaluation of oral deferiprone in Chinese aceruloplasminemia patients.

Clinical Trial Description

Diabetes is one of the most severe symptom in aceruloplasminemia. In this study, we use R2* of pancreas MRI to evaluate the effect of deferiprone treatment. ;

Related Conditions & MeSH terms

• Aceruloplasminemia
• Iron Metabolism Disorders
• Neurodegenerative Diseases

• NCT number: NCT04184453
• Study type: Interventional
• Source: First Affiliated Hospital of Fujian Medical University
• Contact: Jin He
• Phone: 13645050186
• Email: hejin@fjmu.edu.cn
• Status: Recruiting
• Phase: Early Phase 1
• Start date: December 23, 2019
• Completion date: November 23, 2022